vs
QCR HOLDINGS INC（QCRH）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
QCR HOLDINGS INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$107.0M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 16.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -13.2%）
QCR控股有限公司通过旗下子公司，为阔德城和锡达拉皮兹地区的客户提供商业与零售银行服务，以及信托和资产管理服务。公司成立于1993年，总部位于伊利诺伊州莫林市。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
QCRH vs RIGL — 直观对比
营收规模更大
QCRH
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出4.7%
16.5%
两年增速更快
RIGL
近两年复合增速
-13.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 36.1% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 16.5% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $2.10 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QCRHRIGL
| Q4 25 | $107.0M | $69.8M | ||
| Q3 25 | $101.5M | $69.5M | ||
| Q2 25 | $84.2M | $101.7M | ||
| Q1 25 | $76.9M | $53.3M | ||
| Q4 24 | $91.8M | $57.6M | ||
| Q3 24 | $152.6M | $55.3M | ||
| Q2 24 | $150.6M | $36.8M | ||
| Q1 24 | $141.9M | $29.5M |
净利润QCRHRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $36.7M | $27.9M | ||
| Q2 25 | $29.0M | $59.6M | ||
| Q1 25 | $25.8M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $27.8M | $12.4M | ||
| Q2 24 | $29.1M | $-1.0M | ||
| Q1 24 | $26.7M | $-8.2M |
毛利率QCRHRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率QCRHRIGL
| Q4 25 | 36.1% | 33.2% | ||
| Q3 25 | 40.0% | 40.9% | ||
| Q2 25 | 36.3% | 60.1% | ||
| Q1 25 | 34.0% | 23.9% | ||
| Q4 24 | 36.1% | 28.9% | ||
| Q3 24 | 19.6% | 25.4% | ||
| Q2 24 | 21.0% | 1.2% | ||
| Q1 24 | 19.7% | -23.6% |
净利率QCRHRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 36.2% | 40.2% | ||
| Q2 25 | 34.5% | 58.6% | ||
| Q1 25 | 33.6% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 18.2% | 22.5% | ||
| Q2 24 | 19.3% | -2.8% | ||
| Q1 24 | 18.8% | -27.9% |
每股收益（稀释后）QCRHRIGL
| Q4 25 | $2.10 | $14.11 | ||
| Q3 25 | $2.16 | $1.46 | ||
| Q2 25 | $1.71 | $3.28 | ||
| Q1 25 | $1.52 | $0.63 | ||
| Q4 24 | $1.77 | $0.82 | ||
| Q3 24 | $1.64 | $0.70 | ||
| Q2 24 | $1.72 | $-0.06 | ||
| Q1 24 | $1.58 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.1B | $391.5M |
| 总资产 | $9.6B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资QCRHRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务QCRHRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益QCRHRIGL
| Q4 25 | $1.1B | $391.5M | ||
| Q3 25 | $1.1B | $117.6M | ||
| Q2 25 | $1.1B | $81.9M | ||
| Q1 25 | $1.0B | $18.6M | ||
| Q4 24 | $997.4M | $3.3M | ||
| Q3 24 | $976.6M | $-14.6M | ||
| Q2 24 | $936.3M | $-29.9M | ||
| Q1 24 | $907.3M | $-31.7M |
总资产QCRHRIGL
| Q4 25 | $9.6B | $513.6M | ||
| Q3 25 | $9.6B | $242.5M | ||
| Q2 25 | $9.2B | $206.7M | ||
| Q1 25 | $9.2B | $176.0M | ||
| Q4 24 | $9.0B | $164.0M | ||
| Q3 24 | $9.1B | $139.4M | ||
| Q2 24 | $8.9B | $128.4M | ||
| Q1 24 | $8.6B | $126.5M |
负债/权益比QCRHRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $421.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $354.1M | — |
| 自由现金流率自由现金流/营收 | 330.9% | — |
| 资本支出强度资本支出/营收 | 63.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $397.4M | — |
8季度趋势，按日历期对齐
经营现金流QCRHRIGL
| Q4 25 | $421.5M | $22.0M | ||
| Q3 25 | $47.5M | $24.0M | ||
| Q2 25 | $42.2M | $30.5M | ||
| Q1 25 | $-3.6M | $-893.0K | ||
| Q4 24 | $444.5M | $14.5M | ||
| Q3 24 | $238.1M | $21.7M | ||
| Q2 24 | $26.3M | $302.0K | ||
| Q1 24 | $2.7M | $-5.0M |
自由现金流QCRHRIGL
| Q4 25 | $354.1M | — | ||
| Q3 25 | $31.7M | — | ||
| Q2 25 | $24.2M | — | ||
| Q1 25 | $-12.7M | — | ||
| Q4 24 | $400.0M | — | ||
| Q3 24 | $229.9M | — | ||
| Q2 24 | $16.2M | — | ||
| Q1 24 | $-9.4M | — |
自由现金流率QCRHRIGL
| Q4 25 | 330.9% | — | ||
| Q3 25 | 31.3% | — | ||
| Q2 25 | 28.8% | — | ||
| Q1 25 | -16.5% | — | ||
| Q4 24 | 435.6% | — | ||
| Q3 24 | 150.7% | — | ||
| Q2 24 | 10.7% | — | ||
| Q1 24 | -6.6% | — |
资本支出强度QCRHRIGL
| Q4 25 | 63.0% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 21.4% | — | ||
| Q1 25 | 11.9% | — | ||
| Q4 24 | 48.4% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | 8.6% | — |
现金转化率QCRHRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.29× | 0.86× | ||
| Q2 25 | 1.46× | 0.51× | ||
| Q1 25 | -0.14× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 8.57× | 1.75× | ||
| Q2 24 | 0.90× | — | ||
| Q1 24 | 0.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
